Clinical Trials Browser

Phase 2 × troxacitabine × Clear all

NCT00012259 2021-06-10

Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Phase 2 Completed

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00129948 2006-11-03

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute